Cart
sales@molnova.com
AZ5576
CAS No. 2751721-40-9
AZ5576( —— )
Catalog No. M35347 CAS No. 2751721-40-9
AZ5576, a potent and highly selective CDK9 inhibitor, can be used for research on Hematological Malignancy .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | Get Quote |
|
| 5MG | 69 | Get Quote |
|
| 10MG | 109 | Get Quote |
|
| 25MG | 214 | Get Quote |
|
| 50MG | 321 | Get Quote |
|
| 100MG | 449 | Get Quote |
|
| 500MG | 888 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAZ5576
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZ5576, a potent and highly selective CDK9 inhibitor, can be used for research on Hematological Malignancy .
-
DescriptionAZ5576 is a potent and highly selective CDK9 inhibitor (IC50: <5 nM). AZ5576 can be used for hematological Malignancy research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2751721-40-9
-
Formula Weight385.43
-
Molecular FormulaC21H24FN3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (324.31 mM; Ultrasonic )
-
SMILESCOc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@H](C2)NC(C)=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bernard Barlaam, et al. Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies. ?
molnova catalog
related products
-
R-547
A potent, selective and ATP-competitive CDK inhibitor with Ki of 1/3/1 nM for CDK1/2/4, respectively.
-
AT-7519 trifluoroace...
A potent CDK2 inhibitor with IC50 of 47 nM; also inhibits CDK1/4/5 with IC50 of 190/67/18 nM and shows selectivity over some kinases (Aurora A, IR kinase, MEK, PDK1, c-Abl, IC50>10 uM).
-
Voruciclib
A potent, selective and orally bioavailable CDK9 inhibitor with Ki of 0.63 nM and 1.68 nM for CDK9/cyclinT2 and CDK9/cyclinT1.
